CompletedNot Applicable

Gene Analysis in Studying Susceptibility to Wilms Tumor

United States1 participantsStarted 2009-10

Plain-language summary

This clinical trial studies gene analysis in studying susceptibility to Wilms tumor. Finding genetic markers for Wilms tumor may help identify patients who are at risk of relapse.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 3000 samples from the 1958 Birth Cohort (58C) and 3000 from the UK Blood Service control series (NBS)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Frequencies between cases and controls at each SNP

Timeframe: Baseline

Frequency of maternal and paternal allelic transmission for risk alleles

Timeframe: Baseline

Genetic variation on sub-phenotypes such as age at diagnosis, unilateral or bilateral disease, sex, and ethnicity

Timeframe: Baseline

Interactions between genetic variation and treatment success or prognosis

Timeframe: Baseline

Interactions between germline genetic variation and tumor phenotypes

Timeframe: Baseline

Trial details

NCT IDNCT01808079

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2009-11

View on ClinicalTrials.gov More Recurrent Childhood Kidney Neoplasm trials

What they're measuring

Frequencies between cases and controls at each SNP

Timeframe: Baseline

Frequency of maternal and paternal allelic transmission for risk alleles

Timeframe: Baseline

Genetic variation on sub-phenotypes such as age at diagnosis, unilateral or bilateral disease, sex, and ethnicity

Timeframe: Baseline

Interactions between genetic variation and treatment success or prognosis

Timeframe: Baseline

Interactions between germline genetic variation and tumor phenotypes

Timeframe: Baseline